P. Bruning

发表

Factors influencing waist/hip ratio in randomly selected pre- and post-menopausal women in the dom-project (preliminary results).

J. Seidell, I. D. Tonkelaar, P. V. van Noord, 1991, International journal of obesity.

Body fat mass, body fat distribution, and pubertal development: a longitudinal study of physical and hormonal sexual maturation of girls.

P. Bruning, J. Thijssen, C. D. de Ridder, 1992, The Journal of clinical endocrinology and metabolism.

Assessment of anthracycline-related myocardial adrenergic derangement by [123I]metaiodobenzylguanidine scintigraphy.

H. van Tinteren, P. Bruning, R. V. Valdés Olmos, 1995, European journal of cancer.

Body fat mass, body fat distribution, and plasma hormones in early puberty in females.

M. Blankenstein, P. Bruning, J. Thijssen, 1990, The Journal of clinical endocrinology and metabolism.

Final results of a randomized phase III trial comparing cyclophosphamide, epirubicin, and fluorouracil with a dose-intensified epirubicin and cyclophosphamide + filgrastim as neoadjuvant treatment in locally advanced breast cancer: an EORTC-NCIC-SAKK multicenter study.

M. Piccart, P. Therasse, H. Bonnefoi, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

An EORTC pilot study of filgrastim (recombinant human granulocyte colony stimulating factor) as support to a high dose-intensive epiadriamycin-cyclophosphamide regimen in chemotherapy-naive patients with locally advanced or metastatic breast cancer.

M. Piccart, R. Paridaens, J. Schornagel, 1995, Annals of oncology : official journal of the European Society for Medical Oncology.

Detection of lung metastases from osteosarcoma by scintigraphy using 99mTc-methylene diphosphonate.

P. Bruning, C. Hoefnagel, J. van der Schoot, 1981, Diagnostic imaging.

Body fat distribution and obesity in pre- and postmenopausal breast cancer.

R. Shore, P. Bruning, M. Terry, 1999, International journal of epidemiology.

Relation of serum levels of testosterone and dehydroepiandrosterone sulfate to risk of breast cancer in postmenopausal women.

B. Pasternack, R. Shore, A. Zeleniuch‐Jacquotte, 1997, American journal of epidemiology.

Tamoxifen, serum lipoproteins and cardiovascular risk.

A. Hart, P. Bruning, J. van Loon, 1988, British Journal of Cancer.

Re: C-reactive protein and risk of breast cancer.

R. Shore, A. Arslan, A. Zeleniuch‐Jacquotte, 2008, Journal of the National Cancer Institute.

Bone mineral density after adjuvant chemotherapy for premenopausal breast cancer.

A. Hart, P. Bruning, A. E. van den Ende, 1990, British Journal of Cancer.

Insulin‐like growth‐factor‐binding protein 3 is decreased in early‐stage operable pre‐menopausal breast cancer

T. C. Linders, A. Hart, P. V. van Noord, 1995, International journal of cancer.

Endogenous estrogens and breast cancer a possible relationship between body fat distribution and estrogen availability.

P. Bruning, 1987, Journal of steroid biochemistry.

Identification and interpretation of clinical and quality of life prognostic factors for survival and response to treatment in first-line chemotherapy in advanced breast cancer.

J. Klijn, M. Piccart, J. de Haes, 2000, European journal of cancer.

Taxol (T) versus doxorubicin (D) as first-line chemotherapy (CT) in advanced breast cancer (ABC): An EORTC randomized study with crossover

M. Piccart, R. Paridaens, P. Bruning, 1997 .

Treatment of haemophilia B with purified Factor IX (PPSB).

H. Hemker, P. Bruning, J. Veltkamp, 1967, Folia medica Neerlandica.

Randomised trial of paclitaxel versus doxorubicin as first-line chemotherapy for advanced breast cancer: quality of life evaluation using the EORTC QLQ-C30 and the Rotterdam symptom checklist.

J. Klijn, M. Piccart, M. Groenvold, 2000, European journal of cancer.

Growth arrest associated changes of mRNA levels in breast cancer cells measured by semi-quantitative RT-PCR: potential early indicators of treatment response.

H. Peterse, P. Bruning, A. Breedijk, 1995, Cancer letters.

Free fatty acid concentrations correlated with the available fraction of estradiol in human plasma.

P. Bruning, J. Bonfrer, 1986, Cancer research.

Possible Relevance of Steroid Availability and Breast Cancer

P. Bruning, J. Bonfrer, P. Bruning, 1988, Annals of the New York Academy of Sciences.

The binding of blood-borne estrogens in normal vegetarian and omnivorous women and the risk of breast cancer.

I. Fentiman, G. Clark, M. Caleffi, 1988, Nutrition and cancer.

Usefulness of indium-111 antimyosin scintigraphy in confirming myocardial injury in patients with anthracycline-associated left ventricular dysfunction.

H. van Tinteren, P. Bruning, R. V. Valdés Olmos, 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

A Sandwich-Radioimmunoassay for a New Antigen (Mam-6) Present in the Sera of Patients with Metastasized Carcinomas

P. Bruning, J. Bonfrer, J. Hilkens, 1985 .

Why is breast cancer so frequent in The Netherlands?

P. Bruning, N. Russell, A. Ansink, 1988, European Journal of Surgical Oncology.

Dietary habits, sexual maturation, and plasma hormones in pubertal girls: a longitudinal study.

P. Bruning, J. Thijssen, P. van ‘t Veer, 1991, The American journal of clinical nutrition.

Influence of ACTH on aminoglutethimide induced reduction of plasma steroids in postmenopausal breast cancer.

P. Bruning, J. Bonfrer, M. de Jong‐Bakker, 1984, Journal of steroid biochemistry.

Low dose aminoglutethimide without hydrocortisone for the treatment of advanced postmenopausal breast cancer.

A. Hart, P. Bruning, W. Nooijen, 1989, European journal of cancer & clinical oncology.

Immunomagnetic purification of human breast carcinoma cells allows tumor-specific detection of multidrug resistance gene 1-mRNA by reverse transcriptase polymerase chain reaction in fine-needle aspirates.

H. Peterse, P. Bruning, A. Breedijk, 1995, Laboratory investigation; a journal of technical methods and pathology.

Non-protein bound oestradiol, sex hormone binding globulin, breast cancer and breast cancer risk.

A. Hart, P. Bruning, J. Bonfrer, 1985, British Journal of Cancer.

Intracystic Administration of Tc‐99m Colloid Particles to Study Retention and Drainage in Lymphangioma of the Neck

F. Hilgers, P. Bruning, R. Takes, 1994, Clinical nuclear medicine.

The onset of puberty and the availability of sex steroids in female gymnasts

P. Bruning, J. Thijssen, C. D. de Ridder, 1993, American journal of human biology : the official journal of the Human Biology Council.

Doxorubicin-paclitaxel - A safe regimen in terms of cardiac toxicity in metastatic breast carcinoma patients. Results from a European organization for research and treatment of cancer multicenter trial

M. Piccart, M. Nooij, D. Miles, 2003 .

MAM-6, a Carcinoma Associated Marker: Preliminary Characterisation and Detection in Sera of Breast Cancer Patients

P. Bruning, M. V. Vliet, J. Bonfrer, 1985 .

Abdominal fat predominance in women is associated with a decreased prevalence of the high risk P2, DY mammographic breast patterns.

J. Seidell, P. V. van Noord, P. Bruning, 1991, International journal of obesity.

41 Parity and age influence hormonal risk factors of breast cancer

A. Hart, P. Bruning, A. Verstraeten, 1983 .

Glucocorticoid receptor in cultured human skin fibroblasts.

C. Migeon, P. Bruning, W. Meyer, 1979, Journal of steroid biochemistry.

Prothrombal: A New Concentrate of Human Prothrombin Complex for Clinical Use

P. Bruning, E. Loeliger, 1971, British journal of haematology.

Systematic approach to the treatment of chylous leakage after neck dissection

F. Hilgers, A. Balm, P. Bruning, 1996, Head & neck.

Sarcoidosis presenting with diabetes insipidus followed by acute cranial nerve syndrome. A case report.

P. Bruning, W. Luyendijk, R. Hekster, 2009, Acta medica Scandinavica.

Dietary intake, nutritional status and well-being of cancer patients: a prospective study.

R. Hermus, C. Kistemaker, P. Bruning, 1985, European journal of cancer & clinical oncology.

Monitoring Very Low Levels of AFP in the Early Detection of Tumor Recurrency

T. Out, P. Bruning, W. Nooijen, 1984 .

MAM-6 antigen, a new serum marker for breast cancer monitoring.

P. Bruning, J. Bonfrer, J. Hilkens, 1986, Cancer research.

Radioimmunoscintigraphy using iodine-131-anti-CEA monoclonal antibodies and thallium-201 scintigraphy in medullary thyroid carcinoma: a case report.

P. Bruning, C. Hoefnagel, A. V. van Dongen, 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

A study of the value of p53, HER2, and Bcl-2 in the prediction of response to doxorubicin and paclitaxel as single agents in metastatic breast cancer: a companion study to EORTC 10923.

M. J. van de Vijver, D. Larsimont, M. Piccart, 2000, Clinical breast cancer.

Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma

M. Muller, J. Lindeboom, S. Schagen, 1999, Cancer.

EORTC 10968: a phase I clinical and pharmacokinetic study of polyethylene glycol liposomal doxorubicin (Caelyx, Doxil) at a 6-week interval in patients with metastatic breast cancer. European Organization for Research and Treatment of Cancer.

L Biganzoli, M. Piccart, M. Nooij, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Thyrotropin dependent and independent thyroid cell lines selected from FRTL-5 derived tumors grown in nude mice.

J. van den Brink, E. Schuuring, T. D. de Bruin, 1990, Endocrinology.

Efficient selection of high-affinity B cell hybridomas using antigen-coated magnetic beads.

J. van den Brink, P. Bruning, M. de Boer, 1989, Journal of immunological methods.

Paclitaxel versus doxorubicin as first-line single-agent chemotherapy for metastatic breast cancer: a European Organization for Research and Treatment of Cancer Randomized Study with cross-over.

J. Klijn, M. Piccart, R. Paridaens, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Droloxifene, a new anti-oestrogen in postmenopausal advanced breast cancer: preliminary results of a double-blind dose-finding phase II trial.

P. Bruning, Peter F. Bruning, 1992, European journal of cancer.

Insulin resistance and breast‐cancer risk

A. A. Hart, P. V. van Noord, P. Bruning, 1992, International journal of cancer.

Serum insulin‐like growth factor‐I and breast cancer

R. Shore, A. Zeleniuch‐Jacquotte, P. Bruning, 2000, International journal of cancer.

Diagnosis and treatment of malignant pheochromocytoma with 131I-meta-iodobenzylguanidine: a case report.

P. Bruning, C. Hoefnagel, N. Abeling, 1990, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Production of murine monoclonal antibodies against human thyroglobulin using an in vitro immunization procedure in serum-free medium.

P. Bruning, M. de Boer, F. Ossendorp, 1986, Journal of immunological methods.

Iodination of newly synthesized thyroglobulin by FRTL-5 cells is selective and thyrotropin dependent

P. Bruning, F. Ossendorp, J. D. Vijlder, 1989, Molecular and Cellular Endocrinology.

A routine solid-phase assay for the binding capacity of sex hormone binding globulin.

P. Bruning, J. Bonfrer, W. Nooyen, 1985, Clinica chimica acta; international journal of clinical chemistry.

High-performance liquid chromatographic method for the analysis of 10-ethyl-10-deaza-aminopterin and metabolites in plasma.

J. Beijnen, O. van Tellingen, P. Bruning, 1990, Journal of chromatography.

Doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in metastatic breast cancer: The European Organization for Research and Treatment of Cancer 10961 Multicenter Phase III Trial.

M. Piccart, L. Duchateau, C. Lohrisch, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Identi ® cation and interpretation of clinical and quality of life prognostic factors for survival and response to treatment in ® rst-line chemotherapy in advanced breast cancer

J. Klijn, M. Piccart, R. Paridaens, 2000 .

Purification and Clinical Application of the Four Factors of the Prothrombin Complex

P. Bruning, 1969 .

Factor IX concentrate : Preparation by a simple method and clinical use

H. Hemker, A. Swart, P. Bruning, 1970 .

Prostate-specific antigen (PSA). A tissue-specific and sensitive tumor marker.

P. Bruning, J. Bonfrer, T. Mulders, 1990, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Direct evidence for a primary immune response of murine B-lymphocytes after in vitro immunization of dissociated splenocytes.

P. Bruning, M. de Boer, F. Ossendorp, 1987, Hybridoma.

M. Piccart, P. Therasse, H. Bonnefoi, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Reliability of serum prolactin measurements in women.

B. Pasternack, R. Shore, P. Bruning, 1993, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Doxorubicin/paclitaxel

M. Piccart, M. Nooij, L. Duchateau, 2023, Reactions Weekly.

A simple method for the measurement of the steroid fraction bound to sex hormone binding globulin in serum.

P. Bruning, W. Nooijen, J. Bonfrer, 1989, Journal of steroid biochemistry.

Improved method for the quantification of aminoglutethimide in urine samples.

O. van Tellingen, P. Bruning, J. Bonfrer, 1987, Clinica chimica acta; international journal of clinical chemistry.

Patients and Methods Patient Selection

M. Piccart, P. Therasse, H. Bonnefoi, 2003 .

An ongoing European organization for research and treatment of cancer crossover trial comparing single-agent paclitaxel and doxorubicin as first- and second-line treatment of advanced breast cancer.

J. Klijn, R. Paridaens, M. Piccart-Gebhart, 1996, Seminars in oncology.

Doxorubicin‐paclitaxel

M. Piccart, M. Nooij, L. Duchateau, 2003, Cancer.